Given evidence that AT2 cells are a cell of origin for lung adenocarcinoma [29–31], these observations suggest that Kras does not activate Yap directly in lung cells, but rather stimulates proliferation of AT2 cells. Here, KRAS is linked to lung adenocarcinoma.